Featured Book

Treatise

Transgenomic, Inc. Obtains Approval of Merger with Precipio

Thursday, 15 June 2017 06:03
Rate this item
(0 votes)

Transgenomic, Inc.'s stockholders have approved the merger with Precipio Diagnostics, LLC. Upon completion of the merger, the Company expects to meet the requirements for its stock to be relisted on NASDAQ under the new symbol "PRPO."

Please log in or register to view the entire article

Login to post comments

Featured News